Evaluation and prognostic significance of tumor budding in pancreatic ductal adenocarcinomas

被引:6
|
作者
Argon, Asuman [1 ]
Oz, Oezden [2 ]
Kebat, Tulu
机构
[1] Univ Hlth Sci, Izmir Fac Med, Dept Pathol, Izmir, Turkiye
[2] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Pathol, Izmir, Turkiye
关键词
Mesenchymal phenotype; pancreas carcinoma; tumor budding tumor-spesific treatment; EPITHELIAL-MESENCHYMAL TRANSITION; PERINEURAL INVASION; CANCER; EPIDEMIOLOGY; EXPRESSION; INDICATOR; SURVIVAL;
D O I
10.4103/ijpm.ijpm_905_21
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim: In this study, it was aimed to investigate the prognostic importance of Tumor budding (TB) in Pancreatic ductal adenocarcinomas(PDAC) and its correlation with histopathological findings according to the International Tumor Budding Consensus Conference(ITBCC) grading. Material and Methods: A total of 75 patients diagnosed with PDAC were included in this study. The demographic features of the cases (age, sex) and the macroscopic features of the tumors (localization,size) were obtained from the electronic archive system. All Hematoxylin-Eosin-stained sections were re-evaluated in terms of differentiation, presence of lymphovascular (LVI) and perineural invasion(PNI), surgical margin positivity, primary tumor(pT), lymph node metastasis(LNM) and tumor budding. Statistically, Chi-square test, cox-regression and Kaplan-Meier test were performed. Results:Thirty four of the cases were female and 41 were male. The mean age was 64.21 +/- 9.71years. The degree of TB was TB-few in 17 cases, TB-moderate in 25cases, and TB-high in 33cases. LVI, PNI, LNM and TB-high were poor prognostic factors. Moreover, TB-high was related with poor differantiation,LVI,PNI,LNM and short survival time. Tumor budding was independent negative prognostic factor in multivariable model analyzes. Conclusion: ITBCC scoring can also be used in PDACs. In addition, high tumor budding was a poor prognostic feature and might be a target for tumor-specific treatments as it could be a predictive finding for the locally invasive character of the tumor. Evaluation and grading of TB thought to represent EMT may be a histological feature that can be used in tumor selection for advanced molecular methods to identify subtypes that may be associated with poor prognosis and drug resistance.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [1] Prognostic significance of tumor budding in resected pancreatic ductal adenocarcitionia (PDAC)
    Peixoto, Renata D'Alpino
    O'Connor, Kate
    Li-Chang, Hector Hugo
    Kalloger, Steve
    Renouf, Daniel John
    Schaeffer, David
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma
    Ekaterina Petrova
    Verena Zielinski
    Louisa Bolm
    Cleopatra Schreiber
    Juliana Knief
    Christoph Thorns
    Peter Bronsert
    Sylvia Timme-Bronsert
    Dirk Bausch
    Sven Perner
    Tobias Keck
    Ulrich Wellner
    Virchows Archiv, 2020, 476 : 561 - 568
  • [3] Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma
    Petrova, Ekaterina
    Zielinski, Verena
    Bolm, Louisa
    Schreiber, Cleopatra
    Knief, Juliana
    Thorns, Christoph
    Bronsert, Peter
    Timme-Bronsert, Sylvia
    Bausch, Dirk
    Perner, Sven
    Keck, Tobias
    Wellner, Ulrich
    VIRCHOWS ARCHIV, 2020, 476 (04) : 561 - 568
  • [4] Prognostic significance of tumor budding in patients with pancreatic invasive ductal carcinoma who received neoadjuvant therapy
    Ibuki, Emi
    Kadota, Kyuichi
    Kimura, Nachino
    Ishikawa, Ryou
    Oshima, Minoru
    Okano, Keiichi
    Haba, Reiji
    HELIYON, 2024, 10 (01)
  • [5] Prognostic markers in pancreatic ductal adenocarcinomas
    Hezel, Aram F.
    Bardeesy, Nabeel
    CANCER BIOLOGY & THERAPY, 2008, 7 (09) : 1361 - 1362
  • [6] Tumor Budding Is an Independent Adverse Prognostic Factor in Pancreatic Ductal Adenocarcinoma
    O'Connor, K. M.
    Li-Chang, H. H.
    Kalloger, S. E.
    Webber, D. L.
    Owen, D. A.
    Schaeffer, D. F.
    LABORATORY INVESTIGATION, 2014, 94 : 452A - 452A
  • [7] Tumor Budding Is an Independent Adverse Prognostic Factor in Pancreatic Ductal Adenocarcinoma
    O'Connor, K. M.
    Li-Chang, H. H.
    Kalloger, S. E.
    Webber, D. L.
    Owen, D. A.
    Schaeffer, D. F.
    MODERN PATHOLOGY, 2014, 27 : 452A - 452A
  • [8] Tumor Budding Is an Independent Adverse Prognostic Factor in Pancreatic Ductal Adenocarcinoma
    O'Connor, Kate
    Li-Chang, Hector H.
    Kalloger, Steven E.
    Peixoto, Renata D.
    Webber, Douglas L.
    Owen, David A.
    Driman, David K.
    Kirsch, Richard
    Serra, Stefano
    Scudamore, Charles H.
    Renouf, Daniel J.
    Schaeffer, David F.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (04) : 472 - 478
  • [9] Tumor Budding Is an Independent Prognostic Parameter in Ampullary Adenocarcinomas
    Coban, I.
    Ohike, N.
    Kim, G.
    Morohoshi, T.
    Krasinskas, A.
    Basturk, O.
    Bandyopadhyay, S.
    Goodman, M.
    Adsay, N. V.
    MODERN PATHOLOGY, 2010, 23 : 352A - 352A
  • [10] Tumor Budding Is an Independent Prognostic Parameter in Ampullary Adenocarcinomas
    Coban, I.
    Ohike, N.
    Kim, G.
    Morohoshi, T.
    Krasinskas, A.
    Basturk, O.
    Bandyopadhyay, S.
    Goodman, M.
    Adsay, N. V.
    LABORATORY INVESTIGATION, 2010, 90 : 352A - 352A